[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100582854":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":29,"centralContacts":38,"locations":48,"responsibleParty":66,"collaborators":70,"id":78,"slug":79,"hasResults":80,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":84,"eligibilityCriteria":85,"healthyVolunteers":86,"sex":87,"minAge":88,"maxAge":89,"enrollmentInfo":90,"targetDuration":29,"studyType":93,"phases":94,"briefSummary":96,"conditions":97,"keywords":103,"overallStatus":51,"whyStopped":29,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":115},{"fullName":5,"class":6},"Indiana University","OTHER",[8,16,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Placebo\u002FPlacebo, then Salt\u002FPlacebo, then Salt\u002FKetone","ACTIVE_COMPARATOR","Participants will consume each of the supplemental interventions for 10 days (in this assigned order). On Day 10 of each interventional condition, participants will arrive at the laboratory where the investigators will assess resting blood pressure, arterial stiffness, endothelial function, renal blood flow, and submaximal exercise blood pressure reactivity. Blood will be collected to investigate inflammatory and immune responses to the dietary conditions. After a washout period, participants will consume the next assigned supplemental intervention for 10 days, and repeat the Day 10 assessments. After another washout period, participants will consume the final assigned supplemental intervention for 10 days, and again repeat the Day 10 assessments.",[13,14,15],"Dietary Supplement: No Salt, No β-OHB","Dietary Supplement: High Salt, No β-OHB","Dietary Supplement: High Salt, High β-OHB",{"label":17,"type":10,"description":18,"interventionNames":19},"Salt\u002FPlacebo, then Salt\u002FKetone, then Placebo\u002FPlacebo","Participants will consume each of the supplemental interventions for 10 days (in this assigned order). On day 10 of each interventional condition, participants will arrive at the laboratory where the investigators will assess resting blood pressure, arterial stiffness, endothelial function, renal blood flow, and submaximal exercise blood pressure reactivity. Blood will be collected to investigate inflammatory and immune responses to the dietary conditions. After a washout period, participants will consume the next assigned supplemental intervention for 10 days, and repeat the Day 10 assessments. After another washout period, participants will consume the final assigned supplemental intervention for 10 days, and again repeat the Day 10 assessments.",[13,14,15],{"label":21,"type":10,"description":18,"interventionNames":22},"Salt\u002FKetone, then Placebo\u002FPlacebo, then Salt\u002FPlacebo",[13,14,15],[24,30,34],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":29},"DIETARY_SUPPLEMENT","No Salt, No β-OHB","Participants will consume the following for ten days. Enteric capsules will be filled with a dextrose placebo. The placebo supplement will be a β-OHB-free, taste and viscosity-matched, beverage produced by KetoneAid.",[9,21,17],null,{"type":25,"name":31,"description":32,"armGroupLabels":33,"otherNames":29},"High Salt, No β-OHB","Participants will consume the following for ten days. Enteric capsules will be filled with Morton's table salt. Sodium consumption will be normalized to caloric intake (2 mg Sodium\u002FCalorie). The placebo supplement will be a β-OHB-free, taste and viscosity-matched, beverage produced by KetoneAid.",[9,21,17],{"type":25,"name":35,"description":36,"armGroupLabels":37,"otherNames":29},"High Salt, High β-OHB","Participants will consume the following for ten days. Enteric capsules will be filled with Morton's table salt. Sodium consumption will be normalized to caloric intake (2 mg Sodium\u002FCalorie). Ketone beverage will be the β-OHB supplement produced by KetoneAid. Participants will consume 24 mL (12 grams β-OHB) of the ketone beverage three times a day (total 36 grams β-OHB).",[9,21,17],[39,44],{"name":40,"role":41,"phone":42,"phoneExt":29,"email":43},"Austin T Robinson, PhD","CONTACT","5745141034","ausrobin@iu.edu",{"name":45,"role":41,"phone":46,"phoneExt":29,"email":47},"Kallie E Dawkins, MS","8505566251","kaldawki@iu.edu",[49],{"facility":50,"status":51,"city":52,"state":53,"zip":54,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"School of Public Health","RECRUITING","Bloomington","Indiana","47405","United States","US",{"type":58,"coordinates":59},"Point",[60,61],-86.52639,39.16533,{"lat":61,"lon":60},[64],{"name":40,"role":41,"phone":65,"phoneExt":29,"email":43},"574-514-1034",{"type":67,"investigatorFullName":68,"investigatorTitle":69,"investigatorAffiliation":5,"oldNameTitle":29,"oldOrganization":29},"PRINCIPAL_INVESTIGATOR","Austin Robinson","Associate Professor",[71,73,75],{"name":72,"class":6},"University of Utah",{"name":74,"class":6},"University of Missouri-Columbia",{"name":76,"class":77},"National Institute on Aging (NIA)","NIH","100582854","ketone-ester-and-salt-keas-in-older-adults-100582854",false,"NCT06868719","Ketone Ester And Salt (KEAS) in Older Adults","Ketone Supplementation as a Strategy to Reduce the Negative Health Effects of High Dietary Salt in Older Adults","KEAS-O","Inclusion Criteria:\n\n* Between the ages of 60-85\n* Resting blood pressure no higher than 150\u002F90\n* BMI below 35 kg\u002Fm2 (or otherwise healthy)\n* Free of any metabolic disease (diabetes or renal), pulmonary disorders (COPD, severe asthma, or cystic fibrosis), cardiovascular disease (peripheral vascular, cardiac, or cerebrovascular)\n* Do not have any precluding medical conditions that prevent participants from exercising (i.e., cardiovascular issues, or muscle\u002Fjoint issues including painful arthritis) or giving blood (e.g., blood thinners)\n\nExclusion Criteria:\n\n* High blood pressure - greater than150\u002F90 mmHg\n* Obesity (BMI \\> 30 kg\u002Fm2)\n* History of metabolic disease (diabetes or renal disease), pulmonary disorders (e.g., COPD, severe asthma, \\& cystic fibrosis), and cardiovascular disease (peripheral vascular, cardiac, or cerebrovascular).\n* Medical issues that prevent safe exercise (i.e., cardiovascular issues, or muscle\u002Fjoint issues including painful arthritis)\n* Medical issues that prevent giving blood (e.g., blood thinners).\n* Current smoking, using smokeless tobacco, or vaping (within past 12 months)\n* Current pregnancy",true,"ALL","50 Years","85 Years",{"count":91,"type":92},35,"ESTIMATED","INTERVENTIONAL",[95],"NA","Most Americans consume excess dietary salt based on the recommendations set by the American Heart Association and Dietary Guidelines for Americans. High dietary salt impairs blood pressure control by affecting systemic blood vessels and the kidneys. These changes contribute to excess salt consumption being associated with increased risk for chronic kidney disease and cardiovascular disease, the leading cause of death in America. Salt is particularly deleterious in older adults who are more likely to exhibit salt-sensitive hypertension. However, salt consumption remains high in the United States. Thus, there is a critical need for strategies to counteract the effects of high dietary salt as consumption is likely not going to decrease. One promising option is ketones, metabolites that are produced in the liver during prolonged exercise and very low-calorie diets. While exercise and low-calorie diets are beneficial, not many people engage in these activities. Limited evidence indicates that ketone supplements improve cardiovascular health in humans. Additionally, published rodent data indicates that ketone supplements prevent high salt-induced increases in blood pressure, blood vessel dysfunction, and kidney injury. Our human pilot data also indicates that high dietary salt reduces intrinsic ketone production, but it is unclear whether ketone supplementation confers humans' protection against high salt similar to rodents. Therefore, the investigators seek to conduct a short-term high-dietary salt study to determine whether ketone supplementation prevents high dietary salt from eliciting increased blood pressure, blood vessel dysfunction, and kidney injury\u002Fimpaired blood flow. The investigators will also measure inflammatory markers in blood samples and isolate immune cells that control inflammation. Lastly, the investigators will also measure blood ketone concentration and other circulating metabolites that may be altered by high salt, which could facilitate novel therapeutic targets to combat high salt.",[98,99,100,101,102],"Salt; Excess","Hypertension","Aging","Inflammation","Blood Pressure",[102,104,100,101,105],"Salt","Cardiovascular Disease","2026-06-16",{"date":108,"type":109},"2026-06-18","ACTUAL",{"date":111,"type":109},"2025-03-06",{"date":113,"type":92},"2027-12-31",{"name":5,"class":6},1]